News
Save Lives While You Save on Taxes … and Other Ways to Give
With tax season upon us, financial planning is on many people’s minds. While all gifts made by check or credit card are tax-deductible, there are other ways to fund cutting-edge ovarian cancer research that also offer tax benefits…
Congress Poised to Increase Ovarian Cancer Programs Funding
Update: On 3/11/22, President Biden SIGNED the FY2022 spending bill into law, implementing key ovarian cancer program increases…
Melanie Weigert, PhD | Meet a Scientist
Dr. Melanie Weigert, of University of Chicago, is a 2021 recipient of OCRA’s Mentored Investigator Grant. With her project, “Genome-Wide Profiling of 5-hydroxymethylcytosine on Cell-Free DNA,” Dr…
Comprehensive Study Provides Recommendations for Better Ovarian Cancer Patient Care
Key recommendations for improving care of ovarian cancer patients in the United States have been published as part of a collaborative, in-depth initiative spearheaded by the Association of Community Cancer Centers (ACCC) and involving a…
New Study Shows Surgical Removal of Fallopian Tubes Can Reduce Ovarian Cancer Risk
In promising news on the prevention front, one surgical procedure that leaves the ovaries intact may greatly reduce the risk of ovarian cancer…
The Overview: February 2022
This may be a short month, but it’s not short on all the many ways to get involved. In the meantime, we hope you feel the Valentine love from all of us at OCRA. ADVOCACY Spring Advocacy Day is right around the corner, March 7th – 8th…
New Research Shows Cervical Cells May Hold Key to Predicting Ovarian Cancer Risk
Cervical cell samples that are routinely collected as part of Pap smears may hold promise for predicting the risk of ovarian and other cancers, according to recent findings published as two separate papers in Nature — one focused on…
Our Community Needs YOU | Heroes Highlights
The ovarian cancer community is counting on a hero… and that OCRA Hero could be you! If you’re looking to do good in 2022, it can be as simple (and fun!) as turning your favorite activity into a fundraiser…
Study Finds Pfizer-BioNTech COVID-19 Vaccine Safe and Effective for Gynecologic Oncology Patients
A prospective cohort study recently published on Vaccines set out to determine the safety and effectiveness of the Pfizer-BioNTech COVID-19 vaccine for gynecologic cancer patients undergoing chemotherapy treatment around the time of their…
PARP Inhibitors and Ovarian Cancer
Over the past decade, a new class of drugs called PARP inhibitors have been approved by the Food and Drug Administration (FDA) for use in ovarian cancer…
The Overview | January 2022
Happy new year! While the temperatures may be chilly for many of us, we hope everyone is keeping warm with renewed hope for a year of progress toward our mission, and a strong sense of community…
OCRA Awards Two Ovarian Cancer Research Prizes
OCRA is pleased to announce the recipients of two research prizes, selected by members of our Scientific Advisory Committee for their notable contributions to the field of ovarian cancer research and commitment to future discoveries. Dr…